Printer Friendly

THE most commonly used inhaler [...].

THE most commonly used inhaler in Britain may fail to prevent asthma attacks in more than 100,000 children carrying a gene mutation, research suggests.

Salbutamol, which is often referred to as the "blue" inhaler or known under the brand name Ventolin, may have little effect if taken daily. Researchers from the University of Dundee and Brighton and Sussex Medical School found that children with a gene change called Arg16 were at 30% increased risk of asthma attacks compared with those with a normal form of the gene.

All children in the group were taking salbutamol as a reliever inhaler for asthma attacks but were also on a longer-acting inhaler to control symptoms in the long term.

The experts stressed that parents should not panic and children should carry on taking salbutamol until more research is carried out.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Features
Publication:Evening Chronicle (Newcastle, England)
Date:Oct 12, 2009
Previous Article:A CHARITY repeated its calls [...].
Next Article:ACTIVE teenagers may be protected [...].

Related Articles
Asthma and Cataracts.
Gene's link to asthma.
DR SCOTT'S SURGERY; In association with the NHS.
O'Mahony confident on hearing; GAA KERRY DRUG SHOCK AIDAN TO CLEAR NAME.
Now, a GPS-enabled inhaler to pinpoint areas that trigger asthmatic attacks.
Combo inhaler may simplify asthma treatment.
Caffeine may help reduce exercise-induced asthma symptoms.
Regular check-ups help David to manage asthma.
Schering-Plough announces changes to its global collaboration with Novartis to develop combination therapies for asthma and COPD.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |